By Frederick G. Hayden M.D. (auth.), Professor Michel Revel (eds.)
Read Online or Download Clinical Aspects of Interferons PDF
Similar clinical books
An absolutely up to date version of a generally revered vintage at the prognosis and administration of bronchial asthma in a number of sufferer subpopulations. notwithstanding this 5th version keeps to stress the definition, medicines, and use of bronchial asthma therapies, it additionally makes a speciality of the distinctive wishes sufferer, together with the pediatric sufferer, the pregnant sufferer, and the sufferer present process surgical procedure, in addition to at the perennial problems with workout and bronchial asthma, pulmonary aspergillosis, career, leisure drug use, and psychological/social concerns.
This ABC has confirmed itself as a well-liked advent to scientific Haematology, proper either for postgraduate scholars and first care practitioners. Now in its 3rd variation, the ABC of scientific Haematology has been completely revised, that includes the newest remedies for leukemia, antithrombotics and medication for lymphoma and protecting the newest advances in hematology and bone marrow transplantation.
- Concepts, Clinical Developments, and Therapeutic Advances in Cancer Chemotherapy
- Performance, Talk, Reflection: What is Going On in Clinical Ethics Consultation
- Clinical Trials Explained: A Guide to Clinical Trials in the NHS for Healthcare Professionals
- Jones' Clinical Paediatric Surgery: Diagnosis and Management, Sixth Edition
- Oxford American Handbook of Clinical Medicine (2nd Edition) (Oxford American Handbooks in Medicine)
- Atlas of the Sensory Organs: Functional and Clinical Anatomy
Additional info for Clinical Aspects of Interferons
J. Infect. Dis. 148:543-550, 1983. 13. , Hook, S. W. J. Infect. Dis. 148:535-542, 1983. 14. W. E. J. Infect. Dis. 150:181-188, 1984. 15. C. and Dolin, R. Abstr. Twenty-third Interscience Conference on Antimicrobial Agents and Chemotherapy, no. 920, p. 251, 1984. 16. Turner, R. and Meschievitz, C. Abstr. Fourteenth International Congress of Chemotherapy, no. WS-19-8, p. 67, 1985. 17. J. L. Antiviral Res. 3:121-136, 1983. 18. W. and Silver, G~H. J. Infec. Dis. 133:A136-A139, 1976. 19. S. M. J. Interferon Res.
J. Infect. , in press. 52. E. A. J. IFN Res. 6(Supplement 1):31, 1986. 53. M. J. Antiviral Res. ~:241-252, 1986. 2 INTERFERON THERAPY OF HERPES PAPILLOMAVIRUS CONDYLOMATA SIMPLEX DERMAL INFECTIONS AND J. SHOHAM AND M. REVEL Department of Life Sciences, Bar-Ilan University, 52100 Ramat-Gan and Department of Virology, Weizmann Institute of Science, Rehovot, Israel INTRODUCTION Herpes and papilloma virus infections will probably be among the first indications for which interferon (IFN) will find its place as a therapeutic agent.
145:542-546, 1982. 22. Y. W. Br. J. Clin. Pharmac. 3:869-878, 1976. 23. W. G. J. Pharm. Pharmacol. 37:294-297, 1984. 24. G. , Jr. J. Infect. Dis. 150:174-180, m~ - 25. L. J. Antirnicrob. Agents Chemother. 24:713-715, 1983. 26. K. K. J. Infect. Dis. 154:443-447, 1986. 27. K. C. Abstr. Thirteenth International Congress of Chemotherapy, no. 7/1-7, p. 60/20-23, 1983. 28. , personnal communication. 29. F. G. Antimicrob. Agents Chemother. 26:31-34, 1984. 30. , Beutner, K. and Dolin, R. Abstr. Thirteenth International Congress of Chemotherapy, no.
Clinical Aspects of Interferons by Frederick G. Hayden M.D. (auth.), Professor Michel Revel (eds.)